NWSA is navigating a stretch where two divergent forces are pulling at the same time: a sharp short-covering rally follows a Q3 earnings beat, while the Street edges toward cautious optimism after a rare upgrade.
Short interest has fallen sharply over the past week, but the month-long picture is more complex. At 3.95% of free float, the current level is actually 31% higher than it was a month ago — a build in April that has now started to reverse, with short positions dropping 7.6% across this week alone. The retreat from the local peak appears post-earnings: the stock rose just over 3% the day after its Q3 results on May 7, and short shares dropped from around 16 million to under 15 million in the two sessions that followed. The borrow market reflects a lack of urgency — cost to borrow is running near 0.5%, well within the normal range, and availability is extremely loose. Availability stands far above any level that would suggest squeeze pressure, and the 52-week peak in lending utilization sits at just 3.81% — the pool of shares available to borrow is enormous relative to the shorts in the market. For a media company of this size, the short positioning reads as mildly cautious at best, not a structural conviction trade.
Options lean very slightly more defensive than the recent norm. The put/call ratio of 0.0135 is above its 20-day average of 0.0118, with a z-score of roughly 1.5. In absolute terms the ratio is still extremely low — well below 0.02, far from the 52-week high of 1.81 — suggesting that options positioning is overwhelmingly call-weighted. Any drift toward puts is marginal, not a signal that investors are buying serious downside protection.
Analyst activity this week is the more interesting thread. Macquarie upgraded NWSA to Outperform from Neutral on Monday, lifting its price target to $29.40 from $27.00. That move clearly tracked the post-earnings sentiment shift. Against that, Citigroup — a long-standing bull on the name — maintained its Buy on Wednesday but trimmed its target a dollar to $38, keeping that ceiling comfortably above the current price of $26.54. The mean analyst target sits at $34.75, implying roughly 31% of upside from current levels. That gap is notable: the stock still trades at a meaningful discount to consensus. On valuation, the EV/EBITDA multiple of 9.6x has ticked down over both the past week and month, while the P/E of 24.2x has edged up — the cross-current suggesting earnings revisions are running slightly ahead of asset-value re-ratings. The ORTEX short score of 36.9 has drifted lower through the week, consistent with the easing of short interest.
State Street added just under 11.8 million shares in its last reported period (April 30), making it the most active institutional name in recent filings. Vanguard remains the largest holder at nearly 11% of shares, with a smaller but positive adjustment at its March quarter-end filing. Independent Franchise Partners holds 7.1%, a position that has been broadly stable. The $1 billion share buyback program, flagged in a recent 8-K filing, provides a standing source of demand beneath the market. Insider activity in the snapshot is immaterial — small director-level awards and nominal sells at $24.43 on April 8, all in the low hundreds of dollars.
The next earnings event is scheduled for August 7. Between now and then, what the market will be watching is whether the Macquarie upgrade marks a broader inflection in Street sentiment — and whether the post-Q3 short covering continues or finds a floor near current float levels.
See the live data behind this article on ORTEX.
Open NWSA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
